Scarica l'app Stockscreener
36.00
1.21%
-0.44
Xenon Pharmaceuticals Inc Azioni (XENE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
9.64%
123.16
|
112.33 | 109.77 | 96.34 | 94.23 |
| Depreciation and Amortization |
4.94%
0.558
|
0.587 | 0.611 | 0.641 | 0.632 |
| Operating Income/Loss |
9.64%
-123.16
|
-112.33 | -109.77 | -96.34 | -94.23 |
| Nonoperating Income/Loss |
58.74%
11.83
|
7.455 | 5.044 | 6.117 | 8.897 |
| Income/Loss From Continuing Operations Before Tax |
6.15%
-111.32
|
-104.87 | -104.72 | -90.22 | -85.33 |
| Income Tax Expense/Benefit, Deferred |
534.90%
-1.944
|
0.447 | -1.114 | -0.701 | -0.17 |
| Income Tax Expense/Benefit |
77.25%
-0.585
|
-2.571 | 0.538 | 0.677 | -0.626 |
| Net Income/Loss |
8.24%
-110.74
|
-102.30 | -105.26 | -90.90 | -84.71 |
| Basic Average Shares |
14.04%
99.61
|
87.35 | 0.2908 | 79.25 | 78.95 |
| Diluted Average Shares |
14.04%
99.61
|
87.35 | 0.2908 | 79.25 | 78.95 |
| Basic Earnings Per Share |
5.13%
-1.11
|
-1.17 | -1.31 | -1.15 | -1.07 |
| Diluted Earnings Per Share |
5.13%
-1.11
|
-1.17 | -1.31 | -1.15 | -1.07 |
0.08%
3.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):